Disclosures
Dr Iijima received a consulting fee from Bayer Yakuhin, Daiichi Sankyo, and Nippon Boehringer Ingelheim. Dr Nakamura received grants and personal fees from Bayer Yakuhin, Daiichi Sankyo, and Sanofi, and personal fees from Bristol‐Myers Squibb and Nippon Boehringer Ingelheim. Dr Yasuda received grants from Takeda Pharmaceutical, Abbott, and Boston Scientific, and personal fees from Daiichi‐Sankyo and Bristol‐Meyers. Dr Kaikita reports grants from Grants‐in‐Aid for Scientific Research (20K08451) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants and personal fees from Bayer Yakuhin and Daiichi Sankyo. Dr Akao received grants from the Japan Agency for Medical Research and Development, AMED, personal fees from Bristol‐Myers Squibb and Nippon Boehringer Ingelheim, and grants and personal fees from Bayer Yakuhin and Daiichi Sankyo. Dr Ako received personal fees from Bayer Yakuhin and Sanofi and grants and personal fees from Daiichi Sankyo. Dr Matoba received grants from the Japan Cardiovascular Research Foundation and personal fees from Nippon Boehringer Ingelheim, Daiichi Sankyo, AstraZeneca, and Bayer Yakuhin. Dr Miyauchi received personal fees from Amgen Astellas BioPharma, Astellas Pharma, MSD, Bayer Yakuhin, Sanofi, Takeda Pharmaceutical, Daiichi‐Sankyo, Nippon Boehringer Ingelheim, and Bristol‐Myers Squibb. Dr Hagiwara received grants and personal fees from Bayer Yakuhin, grants from Nippon Boehringer Ingelheim, and personal fees from Bristol‐Myers Squibb. Dr Kimura received grants from the Japan Cardiovascular Research Foundation, grants and personal fees from Bayer Yakuhin, Daiichi Sankyo, Sanofi, MSD, and AstraZeneca, and personal fees from Bristol‐Myers Squibb and Nippon Boehringer Ingelheim. Dr Hirayama received grants and personal fees from Boston Scientific Japan, Otsuka Pharmaceutical, Sanofi, Astellas Pharma, Bristol‐Myers Squibb, Daiichi Sankyo, and Bayer Yakuhin, grants from Fukuda Denshi, Abbott Japan, Japan, Takeda Lifeline, Sumitomo Dainippon Pharmaceutical, and personal fees from Toa Eiyo, Nippon Boehringer Ingelheim, Amgen Astellas BioPharma, and AstraZeneca. Dr Ogawa received personal fees from Towa Pharmaceutical, Bristol‐Meyers Squibb, Pfizer, Toa Eiyo, Bayer Yakuhin, and Novartis Pharma. The remaining authors have no disclosures to report.